Financhill
Back

Anheuser-Busch InBev SA/NV Vs. Neurogene Industry Stock Comparison

Sell
40

BUD
Anheuser-Busch InBev SA/NV

Last Price:
55.82
Seasonality Move:
0.89%
Sell
13

NGNE
Neurogene

Last Price:
39.61
Seasonality Move:
50.43%
Sell
40
Anheuser-Busch InBev SA/NV (BUD) is a Sell

Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?

  • The current Anheuser-Busch InBev SA/NV [BUD] share price is $55.80. The Score for BUD is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BUD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $40.00. The Score for NGNE is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BUD Stock Price Chart

What is Anheuser-Busch InBev SA/NV's stock price today?

  • The Anheuser-Busch InBev SA/NV share price today is $55.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BUD is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $40.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

BUD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.17 Sell
Relative Strength Index (14 RSI): 20.35 Sell
Chaikin Money Flow: 1729379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.36 - 65.38) Sell
Bollinger Bands (100): (59.3 - 64.42) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.99 Buy
Relative Strength Index (14 RSI): 39.4 Sell
Chaikin Money Flow: -718137 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

BUD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.33 Sell
20-day SMA: 61.13 Sell
50-day SMA: 63.2 Sell
200-day SMA: 61.77 Sell
8-day EMA: 57.53 Sell
20-day EMA: 60.01 Sell
50-day EMA: 61.82 Sell
200-day EMA: 61.62 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.21 Sell
20-day SMA: 53.69 Sell
50-day SMA: 46.52 Sell
200-day SMA: 38.9 Buy
8-day EMA: 58.17 Sell
20-day EMA: 54.62 Sell
50-day EMA: 48.72 Sell
200-day EMA: 38.46 Buy

Anheuser-Busch InBev SA/NV Earnings Growth & BUD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.40 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Anheuser-Busch InBev SA/NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):